Publication | Open Access

Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors

MedicineImmune Checkpoint InhibitorsAdvanced Nsclc TreatedCancer ManagementOutcomes ResearchImmune Checkpoint InhibitorPerformance StatusCancer TreatmentImmunotherapyOncologyRadiation OncologyLung Cancer